Counterpoint Quantitative Equity Etf Profile

CPAI Etf  USD 39.78  0.30  0.75%   

Performance

Soft

 
Weak
 
Strong

Odds Of Distress

Small

 
High
 
Low
Counterpoint Quantitative is trading at 39.78 as of the 17th of December 2025. This is a 0.75 percent decrease since the beginning of the trading day. The etf's open price was 40.08. Counterpoint Quantitative has about a 35 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of June 2025 and ending today, the 17th of December 2025. Click here to learn more.
Champion Pain Care Corporation operates as a pain management company in the United States. Champion Pain Care Corporation was incorporated in 2009 and is based in New York, New York. CHAMPION PAIN operates under Medical Care Facilities classification in the United States and is traded on PNK Exchange.. The company has 121.81 M outstanding shares. More on Counterpoint Quantitative Equity

Moving together with Counterpoint Etf

  0.7VO Vanguard Mid CapPairCorr
  0.71VXF Vanguard Extended MarketPairCorr
  0.78IJH iShares Core SPPairCorr
  0.73IWR iShares Russell MidPairCorr
  0.78MDY SPDR SP MIDCAPPairCorr
  0.76FV First Trust DorseyPairCorr

Moving against Counterpoint Etf

  0.57NFLX NetflixPairCorr

Counterpoint Etf Highlights

Thematic Ideas
(View all Themes)
Business ConcentrationBroad Equity ETFs, Strategy ETFs, Mid-Cap Blend, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors)
IssuerCounterpoint Mutual Funds, LLC
Inception Date2023-11-28
Entity TypeRegulated Investment Company
Asset Under Management143.74 Million
Asset TypeEquity
CategoryBroad Equity
FocusStrategy
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorUltimus Fund Solutions, LLC
AdvisorCounterpoint Mutual Funds, LLC.
CustodianBrown Brothers Harriman & Co.
DistributorNorthern Lights Distributors, LLC
Portfolio ManagerJoseph Engelberg, Michael Krause
Transfer AgentBrown Brothers Harriman & Co.
ExchangeNYSE Arca, Inc.
Number of Constituents51.0
Market MakerGTS
Total Expense1.63
Management Fee0.65
200 Day M A36.3087
Country NameUSA
50 Day M A39.4662
CodeCPAI
Updated At16th of December 2025
Returns Y T D17.74
NameCounterpoint Quantitative Equity ETF
Currency NameUS Dollar
Currency CodeUSD
Open FigiBBG01KBNLFS4
TypeETF
1y Volatility17.98
Counterpoint Quantitative Equity [CPAI] is traded in USA and was established null. The fund is listed under Mid-Cap Blend category and is part of Health Care Providers & Services family. The entity is thematically classified as Broad Equity ETFs. Counterpoint Quantitative currently have 27.76 K in assets under management (AUM). with the current yeild of 0.0%, while the total return for the last year was 12.9%. Counterpoint Quantitative Equity currently holds about 5.29 K in cash with (72.58 K) of positive cash flow from operations.
Check Counterpoint Quantitative Probability Of Bankruptcy

Geographic Allocation (%)

Counterpoint Quantitative Currency Exposure

Counterpoint Quantitative Equity holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of Counterpoint Quantitative will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in Counterpoint Quantitative Equity.

Top Counterpoint Quantitative Equity Etf Constituents

DKDelek EnergyStockEnergy
GLWCorning IncorporatedStockInformation Technology
ORCLOracleStockInformation Technology
MCKMcKessonStockHealth Care
VSTSVestisStockIndustrials
GTXGarrett MotionStockConsumer Discretionary
HELEHelen of TroyStockConsumer Discretionary
NEMNewmont Goldcorp CorpStockMaterials
More Details

Counterpoint Quantitative Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Counterpoint Quantitative. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

Counterpoint Quantitative Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Counterpoint Quantitative Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Counterpoint Quantitative price patterns.

Counterpoint Quantitative Against Markets

When determining whether Counterpoint Quantitative offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Counterpoint Quantitative's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Counterpoint Quantitative Equity Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Counterpoint Quantitative Equity Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Counterpoint Quantitative Equity. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
The market value of Counterpoint Quantitative is measured differently than its book value, which is the value of Counterpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Counterpoint Quantitative's value that differs from its market value or its book value, called intrinsic value, which is Counterpoint Quantitative's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Counterpoint Quantitative's market value can be influenced by many factors that don't directly affect Counterpoint Quantitative's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Counterpoint Quantitative's value and its price as these two are different measures arrived at by different means. Investors typically determine if Counterpoint Quantitative is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Counterpoint Quantitative's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.